Author name: comtex

As medication demand grows and complexity increases, the often-overlooked pharmaceutical distribution network proves vital to ensuring timely and equitable access. Canada's pharmaceutical supply chain faces growing challenges as the demand for medications continues to rise. Today, the Canadian Association for Pharmacy Distribution Management (CAPDM) released a landmark report-based on analysis conducted by IQVIA Canada-that shines […]

The partnership encourages Canadians to celebrate and host at any time of the year, with La Petite Fenêtre Boursin; a surprise pop-up window for one day only in Toronto and Montreal. Boursinis thrilled to announce a limited-time “cheeseboard” window experience celebrating the joy of gathering, in partnership with acclaimed Canadian chef Laurent Dagenais. Boursin, known

Ferroglobe PLC Schedules Second Quarter 2025 Earnings Call for August 6, 2025 GlobeNewswire July 23, 2025 LONDON, July 23, 2025 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ: GSM) announced today that it will issue second quarter 2025 financial results after the market closes on Tuesday, August 5, 2025, and will host the quarterly earnings call on

IBN Announces Latest Episode of The GotStocks Podcast featuring Trent D'Ambrosio, CEO of BluSky AI Inc. GlobeNewswire July 23, 2025 AUSTIN, Texas, July 23, 2025 (GLOBE NEWSWIRE) — via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode

ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing GlobeNewswire July 23, 2025 Financing provides bridge to multiple potentially significant liquidity events and crypto strategies UNIONDALE, NY, July 23, 2025 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) today announced the closing of a private placement financing with

Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product GlobeNewswire July 23, 2025 An Orphan Drug Designation Could Provide Significant Benefits to Regen SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) — Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provides further insight into its planned Phase 1 clinical trial of HemaXellerate, the

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs GlobeNewswire July 23, 2025 During the year ended April 30, 2025, net cash provided by financing activities was $10.4 million Stockholder equity of $4.0 million at April 30, 2025, including $3.9 million of cash In May 2025, Alzamend dosed the first patient

BitFuFuPool Surpasses 20 EH/s, Ranks Among Top Global Bitcoin Mining Pools GlobeNewswire July 23, 2025 SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that its private-label Bitcoin mining pool, BitFuFuPool, has surpassed 20 exahashes per second (EH/s) in

Byrna Technologies Reports Strong Direct-to-Consumer Prime Day and July 4th Sales, Growth in Brick & Mortar Presence Underscores Omnichannel Growth Momentum GlobeNewswire July 23, 2025 ANDOVER, Mass., July 23, 2025 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of

Humacyte Announces First Symvess(TM) Sale to Military Treatment Facility GlobeNewswire July 23, 2025 Sale follows recent Electronic Catalog (ECAT) listing approval by U.S. Defense Logistics Agency Symvess now available to U.S. Department of Defense and U.S. Department of Veterans Affairs facilities DURHAM, N.C., July 23, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage